Defects in Innate Immunity

 DEFECTS IN INNATE IMMUNITY

Defects in the complement pathway resulting in immunodeficiency are sum-marized in the previous section. Recent work has identified defects in pathways involved in the recognition and response to pathogen-associated molecular patterns. Some of these defects are outlined next.

 

Defective NFκB activation caused by X-linked hypomorphic mutations of the essential modulator gene (NEMO) compromises signaling mechanisms downstream of Toll, IL-1, and TNF-α receptors. These pa-tients are susceptible to infections caused by a range of microorganisms, including mycobacteria, Gram-positive and Gram-negative bacteria, fungi, and viruses.

UNC93B is a protein of the endoplas-mic reticulum involved in Toll-receptor activation. Mutations in UNC93B impair the production of IFN-α and IFN-β in response to HSV and other viruses. Affected patients present with Herpes sim-plex viral encephalitis. Recently, heterozy-gous dominant-negative mutations in the gene encoding toll receptor 3 (TLR3) have been identified in patients with Herpes sim-plex encephalitis. TLR3 is expressed in the central nervous system where it helps to initiate IFN-α and IFN-β responses to viral duble-stranded DNA.

Interleukin-receptor-associated kinase-4 mediates signaling downstream of Toll receptors and members of the IL-1 receptor superfamily. IRAK-4-deficient individuals present during childhood with recurrent, severe, pyogenic sepsis. They are particu-larly susceptible to recurrent pneumococ-cal infections.

 

The signal-transducing molecule STAT-1 is required for signaling via recep-tors to IFN-γ as well as IFN-α and IFN-β. IFN-γ-receptor-mediated signaling involves the dimerization of phosphory-lated STAT-1 molecules. Signaling via IFN-α and IFN-β receptors involves the formation of a complex between STAT-1, STAT-2, and a third protein called inter-feron-stimulated-gene factor 3-γ. Com-plete (homozygous) defects of the signal-transducing molecules STAT-1 results in defective responses to IFN-γ, IFN-α, and IFN-β eater leading to the susceptibility to disseminated mycobacterial infections as well as fatal Herpes simplex viral infection. Partial STAT-1 deficiency, which interferes with STAT-1 dimerization required for sig-nal transduction via IFN-γ receptors, leads to increased susceptibility to mycobacte-rial infections. In these patients, the cellu-lar responses to IFN-α and INF-β is intact, thus preserving antiviral immunity.

The WHIM syndrome is a condition characterized by severe warts, hypogam-maglobulinemia, and neutropenia. This is the first example of an immunodeficiency caused by aberrant chemokine-recep-tor function. WHIM syndrome is caused by a mutation in the gene encoding the CXCR 4 chemokine receptor. The mutant form of this receptor shows enhanced responsiveness to its ligand.

The hyper-IgE syndrome (HIES) is a complex clinical entity characterized by recurrent bacterial (S. aureus, Gram-nega-tive bacteria) and fungal infections of skin, lymph nodes, lungs, bones, and joints. These patients have elevated serum IgE levels, eosinophilia, dermatitis, facial dysmorphic features, delayed shedding of primary dentition, osteopenia, and impaired acute-phase responses during infections. 

Most patients have an autosomal dominant inheritance while others are sporadic cases. Patients with classical HIES have heterozy-gous mutations in the gene encoding the signal-tranducing protein STAT-3. These mutations mainly involve the DNA-bind-ing domain or the SRC homology 2 domain of the protein and are permissive of protein expression. These mutant proteins severely impair the DNA binding of the phosphory-lated STAT-3 dimer in response to IFN-α and responses to the cytokines IL-10 and IL-6. Reduced response to IL-6 would explain the defective acute-phase response, and the defective response to IL-10 explains the overproduction of IgE. STAT-3 is essen-tial for the generation of TH17 cells and for IL-12 signaling, which are required for the secretion of the bactericidal peptides called β-defensins by epithelial cells of the skin and lungs. This may in part explain the increased incidence of severe sepsis.

Comments

Post a Comment

Popular posts from this blog

Tissue Damage Pathways: Hypersensitivity Reactions

TISSUE DAMAGE PATHWAYS Although the major function of the com-ponents of the immune system is to neu-tralize or destroy the invading organisms or antigen, these reactions often cause “bystander” tissue damage as well. These are called  hypersensitivity reactions , and Gell and Coombs conveniently divided them into five types. Hypersensitivity Reactions TYPE I: IMMEDIATE These reactions are those that involve antigens that react with IgE bound to tissue mast cells or basophils. Activation of the mast cell results in the release of large amounts of pharmacologically active sub-stances. These reactions are rapid (hence immediate) and if injected into the skin a “wheel and flare” reaction can be seen within five to ten minutes. Most anti-gens stimulating IgE are either inhaled or ingested. A perfect example of the inhaled antigen is ragweed pollen. The IgE pro-duction requires helper T cells and T-cell-derived cytokines. IL-4 and IL-13 stimulate IgE production while IFN- γ  is inh...
Read more

Rheumatic Fever

Image
  RHEUMATIC FEVER Acute rheumatic fever (ARF) is a delayed, nonsuppurative sequela of a pharyngeal infection with the group A streptococcus. A latent period of two to three weeks fol-lows the initial streptococcal pharyngitis. The latent period remains the same for each individual patient in the event of a recurrence. This suggests that the patient has already been exposed to more than one streptococcal infection in the past. The onset of disease is usually characterized by an acute febrile illness, which may mani-fest itself in one of three classical ways: (1) The patient may present with migratory arthritis predominantly involving the large joints of the body. (2) There may also be concomitant clinical and laboratory signs of carditis and valvulitis, or carditis and valvulitis may be the only signs of an acute episode. (3) There may be involvement of the central nervous system, manifesting itself as Sydenham’s chorea. The clinical episodes are self-limiting but damage to the valv...
Read more

Hematopoietic Stem Cell Transplantation

Image
  HEMATOPOIETIC STEM CELL TRANSPLANTATION   HSCT involves the infusion of immature blood-forming cells into the circulation of a patient to reconstitute the recipient’s bone marrow. HSCT is a promising form of therapy for patients with certain forms of genetic diseases, specific cancers, and vari-ous blood disorders (Table 18.1). The trans-planted hematopoietic stem cells (HSCs) may come from the patient (autologous HSCT) or from a different stem cell donor (allogeneic HSCT). The field of  clinical HSCT  began in  the late 1940s,  when experiments in mice showed that shielding of the spleen allowed animals to survive oth-erwise lethal total-body irradiation. It was not until the seminal publication by E. Donnall Thomas in the 1957  New England Journal of Medicine , however,   that even transiently successful hema-topoietic transplants were first reported in humans; and at least another decade passed before allogeneic marrow graft-ing really began ...
Read more